Antiretroviral therapy coverage in Barbados
Barbados: Antiretroviral therapy coverage was 60.0% in 2024. ▲ Rising
Antiretroviral therapy coverage in Barbados, 2000–2024
Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of people living with HIV.
Analysis
Barbados recorded 60.0% for antiretroviral therapy coverage in 2024. That is the highest value across all 25 years on record.
Compared with earlier readings it is up 1.7% on the previous year and up 30.4% over ten years.
Over the whole period, antiretroviral therapy coverage in Barbados peaked at 60.0% in 2024 and was at its lowest, 0.0%, in 2000.
That places Barbados 106th out of 143 countries with data for 2024, putting it in the middle of the range.
The long-run direction has been consistently rising across the 25 years of available data.
Antiretroviral therapy coverage in Barbados, year by year
| Year | % of people living with HIV | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 3.0% | — |
| 2003 | 18.0% | +500.0% |
| 2004 | 22.0% | +22.2% |
| 2005 | 24.0% | +9.1% |
| 2006 | 26.0% | +8.3% |
| 2007 | 29.0% | +11.5% |
| 2008 | 32.0% | +10.3% |
| 2009 | 35.0% | +9.4% |
| 2010 | 38.0% | +8.6% |
| 2011 | 40.0% | +5.3% |
| 2012 | 43.0% | +7.5% |
| 2013 | 45.0% | +4.7% |
| 2014 | 46.0% | +2.2% |
| 2015 | 47.0% | +2.2% |
| 2016 | 50.0% | +6.4% |
| 2017 | 53.0% | +6.0% |
| 2018 | 55.0% | +3.8% |
| 2019 | 58.0% | +5.5% |
| 2020 | 57.0% | -1.7% |
| 2021 | 59.0% | +3.5% |
| 2022 | 57.0% | -3.4% |
| 2023 | 59.0% | +3.5% |
| 2024 | 60.0% | +1.7% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 18.9% | 0.0% | 35.0% | 10 |
| 2010s | 47.5% | 38.0% | 58.0% | 10 |
| 2020s | 58.4% | 57.0% | 60.0% | 5 |
Countries ranked near Barbados
- 103 Albania 61.0% compare
- 103 Montenegro 61.0% compare
- 103 Timor-Leste 61.0% compare
- 106 Bolivia, Plurinational State of 60.0% compare
- 106 Malaysia 60.0% compare
- 109 North Macedonia 59.0% compare
More health data for Barbados
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.2208 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,453 deaths per 1,000 people (2090)
- Number of infants who die before age 1 4 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -0.5046 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0272 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.5262 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is antiretroviral therapy coverage in Barbados?
- Antiretroviral therapy coverage in Barbados was 60.0% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
- What is the highest antiretroviral therapy coverage recorded in Barbados?
- The highest recorded value was 60.0% in 2024.
- What is the lowest antiretroviral therapy coverage recorded in Barbados?
- The lowest recorded value was 0.0% in 2000.
- How does Barbados rank for antiretroviral therapy coverage?
- Barbados ranks 106th out of 143 countries with data for 2024.
- Is antiretroviral therapy coverage rising or falling in Barbados?
- Over the last ten years it is up 30.4%. The long-run trend across the full record is rising.
- Where does this Barbados data come from?
- The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage (% of people living with HIV). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.